Yehuda R
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York.
ArticlePsychedelics
Patient-Driven Care in Psychedelic Therapy.
ArticlePsychedelics
Can Psychedelics Help Us Reimagine Prevention of Posttraumatic Stress Disorder?
ArticlePsilocybin
Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.
ArticlePsilocybin
Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.
ArticlePsychedelics
Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness.
ArticleKetamine
Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial.
ArticlePsilocybin
Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy.
ArticlePsilocybin
The Epidemiology of Psychedelic Use Among United States Military Veterans.
ArticleMDMA
Effects of MDMA-assisted therapy for PTSD on self-experience.
ArticlePsilocybin
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
ArticlePsychedelics
A Heuristic Approach: Against Consensus Definitions of Psychedelics.
ArticlePsychedelics
Preventing the Gaps in Psychedelic Research from Becoming Practice Pitfalls: A Translational Research Agenda.
ArticlePsychedelics
Reducing the Harms of Nonclinical Psychedelics Use Through a Peer-Support Telephone Helpline.
PreprintMDMA
Self-experience in MDMA assisted therapy of PTSD
ArticlePsychedelics